Ferraro, Simona <br/><br/>
More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application.  [electronic resource] 

 -  Clinical chemistry and laboratory medicine  02 2020 
 - e61-e63 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1437-4331 
<br/><br/><label>Standard No.: </label>10.1515/cclm-2019-0973  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biological Assay<br/>Biomarkers, Tumor<br/>Chorionic Gonadotropin<br/>Chorionic Gonadotropin, beta Subunit, Human<br/>Humans